Press Room

Share

FILTER BY:

November 5, 2025

Denver Voters Prioritize Public Health, Uphold Ordinance to End the Sale of Most Flavored Tobacco Products

On Tuesday, Denver voters passed Proposition 310 to uphold an ordinance ending the sale of menthol cigarettes and most other flavored tobacco products, including but not limited to cigars, chewing tobacco, nicotine pouches and e-cigarettes. The Denver City Council passed the legislation in December 2024. As part of the Denver Kids vs Big Tobacco coalition, the American Cancer Society Cancer Action Network (ACS CAN) supported a YES vote on Proposition 310 to help reduce tobacco use and improve health equity.

October 31, 2025

Washington, D.C. – Open Enrollment for most of the Health Insurance Marketplaces begins tomorrow, Saturday, November 1, and because Congress still has not extended the enhanced premium tax credits, tens of millions of people, including cancer patients and survivors, are facing significant premium increases. 

October 7, 2025

Columbia, S.C. – Join the American Cancer Society Cancer Action Network (ACS CAN) as we celebrate and remember those who’ve faced breast and cervical cancer at the annual Ann Riley Pink Tea on Thursday, October 9 at 10 a.m.

October 3, 2025

A new paper in the Journal of Clinical and Translational Science finds that travel distance to National Cancer Institute (NCI)-funded sites remains a key barrier for patients wanting to participate in clinical trials or research at these locations.

Media Contacts

Emily Burr
Director, Media Advocacy
Medicaid, Patient Navigation
Trista Hargrove
Director, Media Advocacy
Health Equity
Josh Wilson
Senior Manager, Media Advocacy
Cancer Prevention, Tobacco Control

Media Campaigns

ACS CAN’s newest campaign highlights the need to build on proven progress in groundbreaking research with sustained funding increase for the National Institutes of Health and National Cancer Institute.

ACS CAN urges Congress to Fight Cancer and Make Time, literally, for more of life’s moments for patients and survivors by prioritizing cancer research.